0001387131-22-006923.txt : 20220610 0001387131-22-006923.hdr.sgml : 20220610 20220610185954 ACCESSION NUMBER: 0001387131-22-006923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zanganeh Maky CENTRAL INDEX KEY: 0001507650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 221010317 MAIL ADDRESS: STREET 1: MAKY ZANGANEH & ASSOCIATES STREET 2: 51 ADAM WAY CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 zangeneh-form4_060922.xml X0306 4 2022-06-09 0 0001625101 Pulse Biosciences, Inc. PLSE 0001507650 Zanganeh Maky C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 1 0 0 0 Common Stock 2022-06-09 4 X 0 86668 A 442168 D Common Stock 27000 I Immediate family member 1 Common Stock 14000 I Immediate family member 2 Common Stock 107074 I Immediate family member 3 Warrant (right to buy) 2.05 2022-06-09 4 P 0 86668 A 2022-06-09 2027-06-09 Common Stock 86668 86668 D The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2022-06-10